A Korean research team has developed a two-electrode-based real-time diagnostic technology capable of precisely analyzing the ...
In the first ever Q4Bio Challenge, research teams sought to demonstrate scalable quantum algorithms for healthcare, with Algorithmiq's work alongside Cleveland Clinic and IBM earning $2 million Q4Bio ...
Add Yahoo as a preferred source to see more of our stories on Google. Donald Trump speaks during the Republican National Convention on July 18, 2024. in Milwaukee, Wis. (Al Drago / Bloomberg via Getty ...
However, people must first realize there’s a problem and understand how technology can solve it before AI can make a meaningful difference. When things click, it’s always a matter of consumer ...
A second Royal Commission of Inquiry into New Zealand’s experience and handling of the COVID pandemic released its substantial report today, running to several volumes and hundreds of pages. The ...
The next update for Helldivers 2, which will roll out later this month, will fix one of the largest (quite literally) problems that the game has developed. Since launching in 2024, developer Arrowhead ...
China could face ‘real problems’ within two months if Strait of Hormuz crisis drags on, expert warns
With Strait of Hormuz traffic nearly halted, China's reliance on Iranian oil could trigger "real problems" within two months if the crisis continues, one expert warned. Gatestone Institute senior ...
LONDON & NEW YORK--(BUSINESS WIRE)--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation, announced that tomorrow it will ...
A phase 2 asthma study of Upstream Bio’s TSLP receptor antagonist has hit its primary endpoint. But, with only the 12-week regimen achieving a Tezspire-like reduction in the annualized asthma ...
Nektar Therapeutics is basking in the honeyed glow of long-term phase 2 data for its immune asset rezpegaldesleukin in atopic dermatitis, where the candidate successfully reduced the size and ...
From creating one monster to killing another, Christoph Waltz’s winter has been a horror show. The 69-year-old Austrian Oscar winner played Henrich Harlander, Victor Frankenstein’s wealthy benefactor, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results